Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 3, 2007, Pages 262.e1-262.e4

  Rittenberg, Charles ^a   Sullivan, Scott ^a   Istwan, Niki ^b   Rhea, Debbie ^b   Stanziano, Gary ^b   Newman, Roger ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Matria Healthcare Inc   (United States)

Author keywords

17 alpha hydroxyprogesterone caproate; preterm birth prevention; progesterone

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; CLINICAL PRACTICE; COMMUNITY; FEMALE; GESTATION PERIOD; HUMAN; LABOR; MAJOR CLINICAL STUDY; NURSING ASSESSMENT; OUTPATIENT; PATIENT REFERRAL; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS;

EID: 34548494192     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.06.032     Document Type: Article

References (6)

1. Meis P.J., Klevanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
2. American College of Obstetricians and Gynecologists. ACOG committee opinion, number 291. Use of progesterone to reduce preterm birth. Obstet Gynecol 102 (2003) 1115-1116
3. Ness A., Dias T., Damus K., Burd I., and Berghella V. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey. Am J Obstet Gynecol 195 (2006) 1174-1179
4. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
5. Gonzalez-Quintero V.H., Istwan N.B., Rhea D.J., Smarkusky L., Hoffman M.C., and Stanziano G.J. Gestational age at initiation of 17 alpha-hydroxyprogesterone caproate (17P) and recurrent preterm delivery. J Matern Fetal Neonatal Med 20 (2007) 249-252
6. Rebarber A., Ferrara L.A., Hanley M.L., et al. Increased recurrence of preterm delivery with early cessation of 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 224 (2007) e1-e4